Key Insights

Highlights

Success Rate

92% trial completion (above average)

Published Results

54 trials with published results (14%)

Research Maturity

271 completed trials (70% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

6.2%

24 terminated out of 387 trials

Success Rate

91.9%

+5.3% vs benchmark

Late-Stage Pipeline

25%

95 trials in Phase 3/4

Results Transparency

20%

54 of 271 completed with results

Key Signals

54 with results92% success24 terminated

Data Visualizations

Phase Distribution

334Total
Not Applicable (141)
Early P 1 (4)
P 1 (34)
P 2 (60)
P 3 (54)
P 4 (41)

Trial Status

Completed271
Unknown46
Terminated24
Recruiting16
Withdrawn9
Not Yet Recruiting9

Trial Success Rate

91.9%

Benchmark: 86.5%

Based on 271 completed trials

Clinical Trials (387)

Showing 20 of 20 trials
NCT06801067Phase 1RecruitingPrimary

A Study of SER-155 to Treat Diarrhea in People on Immunotherapy

NCT07545759Phase 2Recruiting

A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome-Diarrhea (IBS-D)

NCT07264985Recruiting

Gut Microbiota and Diarrhea in Breast Cancer Patients Receiving Pyrotinib

NCT04038619Phase 1Recruiting

Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients

NCT07300462Phase 4Enrolling By InvitationPrimary

A Post-marketing Observational Study of Oral Cholera Vaccine

NCT07683364Not ApplicableNot Yet Recruiting

Bristol Stool Scale-Based Care Pathway for Enteral Nutrition-Associated Diarrhea in Critically Ill Patients

NCT07668765Not Yet Recruiting

GLP-1 Receptor Agonists and Early Proctologic Effects in Morbid Obesity

NCT02875249CompletedPrimary

Intestinal Microbiome and Chemotherapy

NCT06268717Not ApplicableCompleted

GI Alpha-Gal Study

NCT04826991Not ApplicableActive Not RecruitingPrimary

Wells and Enteric Disease Transmission

NCT06657001Enrolling By Invitation

Enabling Microbiomics- Driven Personalized Nutrition

NCT05933525Phase 2CompletedPrimary

Clinical Study to Assess the Efficacy of Once-daily IMM-124E (Travelan®) in a Controlled Human Infection Model.

NCT07230821Not ApplicableCompleted

Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes

NCT07610382Recruiting

Balanced Crystalloid vs Normal Saline in Pediatric Acute Gastroenteritis

NCT07601503Not ApplicableNot Yet RecruitingPrimary

Evaluating In-line Chlorination in Nigeria

NCT05776914Phase 2Recruiting

Fecal Microbiota Transplantation for IBS

NCT07569172Not ApplicableNot Yet Recruiting

Improved Child Nutrition and Development Through Social Transfers

NCT05372068Not ApplicableActive Not Recruiting

Cement flooRs AnD chiLd hEalth (CRADLE)

NCT00093353Phase 1CompletedPrimary

N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant Neuroblastoma

NCT05814042Phase 2CompletedPrimary

Next Generation ORS: Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea

Scroll to load more

Research Network

Activity Timeline